Early amyloid accumulation in the hippocampus of SAMP8 mice
- PMID: 20061609
- DOI: 10.3233/JAD-2010-1321
Early amyloid accumulation in the hippocampus of SAMP8 mice
Abstract
Late-onset Alzheimer's disease (AD) is the most common form of AD appearing after 65 years of age. To date, however, there are no non-genetically manipulated rodent models that develop a similar sporadic onset of AD with age-related amyloid-beta (Abeta) deposition. Although the senescence accelerated mouse prone 8 (SAMP8) mice have been proposed as a model of AD, the presence of Abeta deposits remains controversial. In this study, we describe the time course of Abeta deposition in SAMP8 mice as well as in control SAMR1 and ICR-CD1 strains of mice. From as early as 6 months onward, SAMP8 mice show Abeta deposition in the hippocampus that increase in number and extent with age. These deposits are comprised of by clustered granules that contain Abeta{42}, Abeta{40}, and other Abeta protein precursor fragments. By marked contrast, control mice show only low numbers of Abeta clusters that do not develop until 15 months of age. The demonstration that SAMP8 mice present with amyloid deposits in their hippocampus makes this animal model a useful tool to understand the mechanisms involved in Abeta deposition in AD.
Similar articles
-
Characterization of amyloid-β granules in the hippocampus of SAMP8 mice.J Alzheimers Dis. 2011;25(3):535-46. doi: 10.3233/JAD-2011-101713. J Alzheimers Dis. 2011. PMID: 21460438
-
Possible involvement of transthyretin in hippocampal beta-amyloid burden and learning behaviors in a mouse model of Alzheimer's disease (TgCRND8).Neurodegener Dis. 2010;7(1-3):88-95. doi: 10.1159/000285513. Epub 2010 Feb 18. Neurodegener Dis. 2010. PMID: 20173334
-
Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.Neurobiol Dis. 2006 Sep;23(3):653-62. doi: 10.1016/j.nbd.2006.05.010. Epub 2006 Jul 10. Neurobiol Dis. 2006. PMID: 16829076
-
Do amyloid β-associated factors co-deposit with Aβ in mouse models for Alzheimer's disease?J Alzheimers Dis. 2010;22(2):345-55. doi: 10.3233/JAD-2010-100711. J Alzheimers Dis. 2010. PMID: 20847441 Review.
-
[The lesions of Alzheimer's disease: which therapeutic perspectives?].Bull Acad Natl Med. 2008 Feb;192(2):303-18; discussion 318-21. Bull Acad Natl Med. 2008. PMID: 18819685 Review. French.
Cited by
-
Amyloid and tau pathology of familial Alzheimer's disease APP/PS1 mouse model in a senescence phenotype background (SAMP8).Age (Dordr). 2015 Feb;37(1):9747. doi: 10.1007/s11357-015-9747-3. Epub 2015 Feb 8. Age (Dordr). 2015. PMID: 25663420 Free PMC article.
-
Manual Acupuncture Regulates Behavior and Cerebral Blood Flow in the SAMP8 Mouse Model of Alzheimer's Disease.Front Neurosci. 2019 Jan 31;13:37. doi: 10.3389/fnins.2019.00037. eCollection 2019. Front Neurosci. 2019. PMID: 30766475 Free PMC article.
-
The phosphatidyl inositol 3 kinase-glycogen synthase kinase 3β pathway mediates bilobalide-induced reduction in amyloid β-peptide.Neurochem Res. 2012 Feb;37(2):298-306. doi: 10.1007/s11064-011-0612-1. Epub 2011 Sep 28. Neurochem Res. 2012. PMID: 21952928
-
Multidentate (18)F-polypegylated styrylpyridines as imaging agents for Aβ plaques in cerebral amyloid angiopathy (CAA).J Med Chem. 2011 Dec 8;54(23):8085-98. doi: 10.1021/jm2009106. Epub 2011 Nov 9. J Med Chem. 2011. PMID: 22011144 Free PMC article.
-
Dietary resveratrol prevents Alzheimer's markers and increases life span in SAMP8.Age (Dordr). 2013 Oct;35(5):1851-65. doi: 10.1007/s11357-012-9489-4. Epub 2012 Nov 7. Age (Dordr). 2013. PMID: 23129026 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical